We have located links that may give you full text access.
Generation of β cells from iPSC of a MODY8 patient with a novel mutation in the carboxyl ester lipase (CEL) gene.
Journal of Clinical Endocrinology and Metabolism 2021 January 9
CONTEXT: MODY8 is a rare form of monogenic diabetes characterized by a mutation in CEL (carboxyl-ester-lipase) gene, which leads to exocrine pancreas dysfunction, followed by β cell failure. Induced pluripotent stem cells can differentiate into functional β cells. Thus, β cells from MODY8 patients can be generated in vitro and used for disease modelling and cell replacement therapy.
DESIGN AND RESULTS: A genetic study was performed in a patient suspected of monogenic diabetes. A novel heterozygous pathogenic variant in CEL (c.1818delC) was identified in the Proband, allowing diagnosis of MODY8. Three MODY8-iPSC clones were reprogrammed from skin fibroblasts of the patient, and their pluripotency and genomic stability confirmed. All three MODY8-iPSC differentiated into β cells following developmental stages. MODY8-iPSC-derived β cells were able to secrete insulin upon glucose dynamic perifusion. CEL gene was not expressed in iPSC nor during any steps of endocrine differentiation.
CONCLUSIONS: iPSC lines from a MODY8 patient with a novel pathogenic variant in the CEL gene were generated, they are capable of differentiation into endocrine cell and β cell function is preserved in mutated cells. These results set the basis for in vitro modelling of the disease and potentially for autologous β cell replacement.
DESIGN AND RESULTS: A genetic study was performed in a patient suspected of monogenic diabetes. A novel heterozygous pathogenic variant in CEL (c.1818delC) was identified in the Proband, allowing diagnosis of MODY8. Three MODY8-iPSC clones were reprogrammed from skin fibroblasts of the patient, and their pluripotency and genomic stability confirmed. All three MODY8-iPSC differentiated into β cells following developmental stages. MODY8-iPSC-derived β cells were able to secrete insulin upon glucose dynamic perifusion. CEL gene was not expressed in iPSC nor during any steps of endocrine differentiation.
CONCLUSIONS: iPSC lines from a MODY8 patient with a novel pathogenic variant in the CEL gene were generated, they are capable of differentiation into endocrine cell and β cell function is preserved in mutated cells. These results set the basis for in vitro modelling of the disease and potentially for autologous β cell replacement.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app